Smruthi Organics Ltd

Smruthi Organics, a microcap in the Pharmaceuticals & Drugs sector, reached a new 52-week low today, reflecting significant volatility. The stock has underperformed its sector and is trading below key moving averages, indicating a bearish trend. Over the past year, it has declined notably compared to the Sensex.

Smruthi Organics has reported its financial results for the quarter ending December 2024, showing significant improvements in various metrics. The company achieved a Profit After Tax of Rs 2.26 crore and an operating profit of Rs 4.16 crore, reflecting enhanced operational efficiency and effective receivables management.

Smruthi Organics, a microcap pharmaceutical company, has been facing a downward trend in the market, with a 52-week low on November 22, 2024. The stock has been underperforming and received a 'Sell' call from MarketsMOJO. It is currently trading below its moving averages and has had a negative performance compared to the Sensex.

Smruthi Organics, a microcap pharmaceutical company, has been underperforming in the market with a 'Sell' call from MarketsMOJO. On November 21, the stock hit a 52-week low of Rs.115, marking the third consecutive day of losses. It is currently trading below its moving averages and has seen a -40.01% decline in the past year.

Smruthi Organics, a microcap pharmaceutical company, has reported a flat performance in the second quarter of fiscal year 2024-2025. However, there has been an improvement in the company's score and a significant increase in Profit Before Tax. On the other hand, Profit After Tax has decreased, indicating a negative trend. Investors should carefully consider all factors before making any investment decisions.

Smruthi Organics, a microcap pharmaceutical company, has hit a 52-week low in its stock price on November 14, 2024. According to MarketsMOJO, the stock has been given a Strong Sell rating and is currently trading below its moving averages. In the past year, the stock has seen a decline of -35.21%, while the Sensex has shown a positive performance of 19.88%. Investors may want to carefully consider this information before making any decisions.

Smruthi Organics, a microcap pharmaceutical company, has recently hit a 52-week low on November 13th, 2024, with a stock call of 'Strong Sell' from MarketsMOJO. The stock is currently trading below its moving averages and has underperformed the sector and Sensex, indicating a downward trend. Investors should approach with caution.

Smruthi Organics, a microcap pharmaceutical company, has been underperforming in the market with a -2.48% decrease compared to its peers. This has resulted in a 'Strong Sell' call by MarketsMOJO. The stock has also hit a 52-week low and is currently trading below its moving averages, indicating a bearish trend.

Smruthi Organics, a microcap pharmaceutical company, has hit a 52-week low on October 25th, 2024, with its stock price falling to Rs.126.05. The stock has underperformed the sector and is currently trading below its moving averages. In comparison to the Sensex, the company has shown a negative 1-year performance, highlighting potential challenges in the current market conditions.

Smruthi Organics, a microcap pharmaceutical company, has hit a 52-week low in its stock price on October 22, 2024. According to MarketsMOJO, the stock has been given a Strong Sell rating and has underperformed the sector by -3.01%. The stock has been on a downward trend, trading below its moving averages, with a decline of -26.88% in the past year. Investors should carefully consider the company's current performance and conduct thorough research before making any investment decisions.

Smruthi Organics, a microcap pharmaceutical company, has recently hit a 52-week low on October 8th, 2024, leading to a 'Strong Sell' call by MarketsMOJO. The stock has been on a downward trend for the past 6 days and is currently trading below its moving averages. In the past year, it has shown a negative performance compared to the positive performance of the Sensex.

Smruthi Organics, a microcap pharmaceutical company, has hit a 52-week low on October 7th, 2024. The stock has been on a downward trend for the past 6 days, with a consecutive fall of -8.1% in returns. According to MarketsMOJO, the stock has been given a 'Strong Sell' call due to its bearish trend and underperformance compared to the Sensex.

Smruthi Organics, a microcap pharmaceutical company, has hit a 52-week low on October 4th, 2024, according to MarketsMOJO. The stock has been underperforming the sector and has seen a downward trend for the past 5 days. It is currently trading below its moving averages, with a 1-year performance of -33.27%. Further research is advised before investing.

Smruthi Organics, a microcap pharmaceutical company, has reported a decline in its financial performance for the quarter ending June 2024. The company's score has fallen from 3 to -10, with a significant decrease in its Profit Before Tax and Profit After Tax. Net Sales have also fallen, and the Debtors Turnover Ratio is at its lowest in five half-yearly periods. Investors should carefully consider these factors before making any investment decisions.

Smruthi Organics, a microcap pharmaceutical company, has received a 'Hold' rating from MarketsMOJO due to its high management efficiency and strong ability to service debt. Technical trends and multiple factors also suggest a bullish outlook for the stock. However, its recent financial performance has been impacted by a decline in profits. Majority shares held by promoters indicate potential for growth in the industry.

Smruthi Organics, a microcap pharmaceutical company, has received a 'Sell' rating from MarketsMOJO due to its flat results in the March 2024 quarter and low Debtors Turnover Ratio. Despite showing high management efficiency and strong ability to service debt, the stock's technical trend is sideways and profits have fallen. Majority shareholders being promoters raises concerns about future growth.

Smruthi Organics, a microcap pharmaceutical company, has received a 'Hold' rating from MarketsMOJO due to its high management efficiency and strong ability to service debt. The stock is currently in a Mildly Bullish range and has shown improvement from a Sideways trend. Its fair valuation and majority promoter ownership make it a promising hold for investors.

Smruthi Organics, a microcap pharmaceutical company, has received a 'Sell' rating from MarketsMOJO due to its flat results in March 2024 and a decrease of -65.33% in profits compared to the previous year. The company's debtors turnover ratio is also at its lowest at 3.11 times. Despite some positive factors, the stock is currently trading at a discount and has underperformed the market in the past year. MarketsMOJO advises investors to carefully consider these factors before making any investment decisions.

Smruthi Organics, a microcap pharmaceutical company, has reported a flat performance in the quarter ending March 2024, with a score of 5 compared to -20 in the previous 3 months. However, there are positive signs such as a 140.7% increase in PBT and a 120.3% increase in PAT, indicating potential for growth.